Microbial nitrogen fertilizer could replace up to 50% of synthetic N

Microbial nitrogen fertilizer could eventually replace as much as half of synthetic nitrogen use, according to a November 10 commentary in Nature Biotechnology. The figure is a long-term ceiling proposed by researchers, not a result demonstrated in commercial fields; Switch Bioworks is testing its engineered microbes while Pivot Bio’s products are further along in market use.
The 50% estimate puts a potential scale on biological nitrogen fixation, but the gap between a technical target and a dependable fertilizer replacement remains substantial. The same commentary discussed environmental gains from partial replacement, while earlier Fertilizer Daily coverage of the Switch Bioworks paper focused on the research priorities needed to improve microbial performance.
Switch founder and CEO Tim Schnabel told AgFunderNews that replacing about 25% of nitrogen fertilizer while maintaining yields would be a meaningful commercial outcome. He described roughly 50% as the likely upper limit for biological systems. Switch’s current field trials are designed to test whether its microbes colonize corn roots and activate nitrogen production, not to establish a statistically reliable fertilizer-replacement or yield result in their first season.
Microbial nitrogen fertilizer remains at different commercial stages
Switch and Pivot are pursuing different engineering routes. Pivot Bio edits genes within its bacterial strains to keep nitrogen fixation active when other nitrogen is present. Its chief technology officer, Travis Frey, told Nature that the company has applied its products across tens of millions of hectares over the past decade. Pivot has reported field-test replacement of roughly 20% to 25% of conventional nitrogen rates, a company figure that should not be treated as an independently established result across all crops and farms.
Switch, which expanded its Midwest corn trials this year, aims to delay nitrogen production until microbes have established themselves on plant roots. Nitrogen fixation consumes energy, and microbes that produce ammonia too early may lose the ability to compete with native soil organisms. Switch says a genetic switch lets its strains first grow and colonize, then activate ammonia production after conditions change.
The distinction also affects regulatory status. Nature reported that Switch’s product uses genetic material from other organisms and is transgenic, while Pivot’s products rely on edits to the bacteria’s own genes. Switch has received authorization for field trials in the U.S. and Brazil, according to reporting on the company’s program; the trials are testing microbial establishment and switch behavior rather than proving commercial nitrogen delivery.
Field evidence and yield parity will determine the ceiling
For growers, the relevant measure is not the percentage a microbe can theoretically replace, but whether it supplies usable nitrogen without reducing yield or adding application risk. Switch’s trials are measuring root colonization, activation timing, plant nitrogen-response indicators, and yield. Schnabel said the current trials are not statistically powered to show fertilizer replacement or yield gains in their first year.
That limitation matters because microbial products are exposed to variable soils, weather, and native microbial communities. Other companies, including BioConsortia with its nitrogen-fixing seed treatment, face the same hurdle. Nature Biotechnology’s commentary identifies better testing and improved microbial establishment as continuing challenges. A broad upper-bound estimate does not establish performance across crops or growing conditions, and no commercial-scale result in the material reviewed here demonstrates a 50% reduction in synthetic nitrogen use.
The economic case will also depend on cost per acre, consistency, and yield parity. Schnabel told AgFunderNews that even savings of $20 to $30 per acre could matter to growers, but that is a company executive’s assessment, not a disclosed product price or independently validated farm-level return. Neither company has shown that the 50% ceiling is commercially attainable across broad acreage.
Commercialization depends on repeatable field performance
Pivot’s reported acreage and field-use history give it a commercial head start, while Switch is still testing a newer system that must prove it can establish reliably before producing nitrogen. The approaches are not yet directly comparable: the published 20% to 25% figure is a Pivot-reported field replacement claim, while the 50% figure is a projected biological upper limit discussed by researchers and Switch’s CEO.
The researchers’ affiliations also warrant context. Several authors of the Nature Biotechnology commentary work for and hold equity in Switch, while two are scientific advisers to Pivot, and the paper discloses those interests. Wider, longer field trials that measure nitrogen transfer and yield will determine whether the proposed ceiling can translate into dependable savings for farmers.
Source: BigGo Finance

Enjoyed this story?
Every Monday, our subscribers get their hands on a digest of the most trending agriculture news. You can join them too!









Discussion0 comments